Sangamo BioSciences   Report issue

For profit Phase 1 Phase 2
Founded: Richmond CA United States (1995)

Organization Overview

First Clinical Trial
2005
NCT00110500
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Sangamo BioSciences, Inc | Sangamo BioSciences, Inc. | Sangamo Therapeutics | Sangamo Therapeutics, Inc.